Synthesis,structural and chemosensitivity studies of arene d6 metal complexes having N‐phenyl‐N´‐(pyridyl/pyrimidyl)thiourea derivatives

The d⁶ metal complexes of thiourea derivatives were synthesized to investigate its cytotoxicity. Treatment of various N‐phenyl‐N´ pyridyl/pyrimidyl thiourea ligands with half‐sandwich d⁶ metal precursors yielded a series of cationic complexes. Reactions of ligand (L1‐L3) with [(p‐cymene)RuCl₂]₂ and [Cp*MCl₂]₂ (M = Rh/Ir) led to the formation of a series of cationic complexes bearing general formula [(arene)M(L1)к²_(N,S)Cl]⁺, [(arene)M(L2)к²_(N,S)Cl]⁺ and [(arene)M(L3)к²_(N,S)Cl]⁺ [arene = p‐cymene, M = Ru ( 1 , 4 , 7 ); Cp*, M = Rh ( 2 , 5 , 8 ); Cp*, Ir ( 3 , 6 , 9 )]. These compounds were isolated as their chloride salts. X‐ray crystallographic studies of the complexes revealed the coordination of the ligands to the metal in a bidentate chelating N,S‐ manner. Further the cytotoxicity studies of the thiourea derivatives and its complexes evaluated against HCT‐116 (human colorectal cancer), MIA‐PaCa‐2 (human pancreatic cancer) and ARPE‐19 (non‐cancer retinal epithelium) cancer cell lines showed that the thiourea ligands displayed no activity. Upon complexation however, the metal compounds possesses cytotoxicity and whilst potency is less than cisplatin, several complexes exhibited greater selectivity for HCT‐116 or MIA‐PaCa‐2 cells compared to ARPE‐19 cells than cisplatin in vitro. Rhodium complexes of thiourea derivatives were found to be more potent as compared to ruthenium and iridium complexes.     

Half‐sandwich ruthenium,rhodium and iridium complexes featuring oxime ligands: Structural studies and preliminary investigation of in vitro and in vivo anti‐tumour activities

Half‐sandwich ruthenium, rhodium and iridium complexes ( 1 – 12 ) were synthesized with aldoxime ( L1 ), ketoxime ( L2 ) and amidoxime ( L3 ) ligands. Ligands have the general formula [PyC(R)NOH], where R = H ( L1 ), R = CH₃ ( L2 ) and R = NH₂ ( L3 ). Reaction of [{(arene)MCl₂}₂] (arene = p ‐cymene, benzene, Cp*; M = Ru, Rh, Ir) with ligands L1 – L3 in 1:2 metal precursor‐to‐ligand ratio yielded complexes such as [{(arene)MLκ²_(N∩N)Cl}]PF₆. All the ligands act as bidentate chelating nitrogen donors in κ²_(N∩N) fashion while forming complexes. In vitro anti‐tumour activity of complexes 2 and 10 against HT‐29 (human colorectal cancer), BE (human colorectal cancer) and MIA PaCa‐2 (human pancreatic cancer) cell lines and non‐cancer cell line ARPE‐19 (human retinal epithelial cells) revealed a comparable activity although complex 2 demonstrated greater selectivity for MIA PaCa‐2 cells than cisplatin. Further studies demonstrated that complexes 3 , 6 , 9 and 12 induced significant apoptosis in Dalton's ascites lymphoma (DL) cells. In vivo anti‐tumour activity of complex 2 on DL‐bearing mice revealed a statistically significant anti‐tumour activity (P  = 0.0052). Complexes 1 – 12 exhibit HOMO–LUMO energy gaps from 3.31 to 3.68 eV. Time‐dependent density functional theory calculations explain the nature of electronic transitions and were in good agreement with experiments.     

Pyrazole Based Mono‐ and Di‐Substituted Half Sandwich d6 Platinum Group Metal Complexes: Synthesis and Spectral Characterization

Reactions of pyrazole based ligand and halide bridged arene d⁶ metal precursors resulted a series of mono and di‐substituted pyrazole based half sandwich d⁶ metal complexes. In general, they are formulated as [(arene)MLCl₂] [M = Ru, arene = benzene ( 1 ), p‐cymene ( 2 ), arene = Cp*, M = Rh ( 3 ) and Ir ( 4 )] and [(arene)ML₂Cl] [M = Ru, arene = benzene ( 5 ), p‐cymene ( 6 ), arene = Cp*, M = Rh ( 7 ) and Ir ( 8 )]. All these complexes were characterized by various spectroscopic techniques (IR, ¹H NMR, ESI‐MS, and UV/Vis). The molecular structures were confirmed by single‐crystal X‐ray diffraction technique. Spectroscopic studies revealed that complexation i.e., mono‐ and di‐substitution occurred by the ratio‐based reaction between pyrazole ligand and metal precursor through the neutral nitrogen rather than protic nitrogen. In these complexes deprotonation of the protic nitrogen does not occur unlike the other complexes containing pyrazole derivatives, in which the pyrazole ligand is anionic.     

Study of the Bonding Modes of Di‐2‐pyridyl ketoxime Ligand towards Ruthenium,Rhodium and Iridium Half Sandwich Complexes

The bonding modes of the ligand di‐2‐pyridyl ketoxime towards half‐sandwich arene ruthenium, Cp*Rh and Cp*Ir complexes were investigated. Di‐2‐pyridyl ketoxime {pyC(py)NOH} react with metal precursor [Cp*IrCl₂]₂ to give cationic oxime complexes of the general formula [Cp*Ir{pyC(py)NOH}Cl]PF₆ ( 1a ) and [Cp*Ir{pyC(py)NOH}Cl]PF₆ ( 1b ), for which two coordination isomers were observed by NMR spectroscopy. The molecular structures of the complexes revealed that in the major isomer the oxime nitrogen and one of the pyridine nitrogen atoms are coordinated to the central iridium atom forming a five membered metallocycle, whereas in the minor isomer both the pyridine nitrogen atoms are coordinated to the iridium atom forming a six membered metallacyclic ring. Di‐2‐pyridyl ketoxime react with [(arene)MCl₂]₂ to form complexes bearing formula [(p‐cymene)Ru{pyC(py)NOH}Cl]PF₆ ( 2 ); [(benzene)Ru{pyC(py)NOH}Cl]PF₆ ( 3 ), and [Cp*Rh{pyC(py)NOH}Cl]PF₆ ( 4 ). In case of complex 3 the ligand coordinates to the metal by using oxime nitrogen and one of the pyridine nitrogen atoms, whereas in complex 4 both the pyridine nitrogen atoms are coordinated to the metal ion. The complexes were fully characterized by spectroscopic techniques.     

Synthesis and characterization of half-sandwich iridium(III) and rhodium(III) complexes bearing organochalcogen ligands

Reactions of [Cp*M(μ-Cl)Cl]₂ (M = Ir, Rh; Cp* = η⁵-pentamethylcyclopentadienyl) with bi- or tri-dentate organochalcogen ligands Mbit (L1), Mbpit (L2), Mbbit (L3) and [Tm^Me]⁻ (L4) (Mbit = 1,1′-methylenebis(3-methyl-imidazole-2-thione); Mbpit = 1,1′-methylene bis (3-iso-propyl-imidazole-2-thione), Mbbit = 1,1′-methylene bis (3-tert-butyl-imidazole-2-thione)) and [Tm^Me]⁻ (Tm^Me = tris (2-mercapto-1-methylimidazolyl) borate) result in the formation of the 18-electron half-sandwich complexes [Cp*M(Mbit)Cl]Cl (M = Ir, 1a; M = Rh, 1b), [Cp*M(Mbpit)Cl]Cl (M = Ir, 2a; M = Rh, 2b), [Cp*M(Mbbit)Cl]Cl (M = Ir, 3a; M = Rh, 3b) and [Cp*M(Tm^Me)]Cl (M = Ir, 4a; M = Rh, 4b), respectively. All complexes have been characterized by elemental analysis, NMR and IR spectra. The molecular structures of 1a, 2b and 4a have been determined by X-ray crystallography.     

Organoruthenium (II) complexes featuring pyrazole‐linked Schiff base ligands: Crystal structure,DNA/BSA interactions,cytotoxicity and molecular docking

Half‐sandwiched ruthenium (II) arene complexes with piano stool‐like geometry with the general formula [(p‐cymene)RuClL¹] and [(p‐cymene)RuClL²] [where L¹ = (Z)‐N′‐((1,3‐diphenyl‐1H‐pyrazol‐4‐yl)methylene)furan‐2‐carbohydrazide and L² = (Z)‐N′‐((1,3‐diphenyl‐1H‐pyrazol‐4‐yl)methylene)thiophene‐2‐carbohydrazide] were synthesized and characterized. The single crystal X‐ray data revealed that the complexes belong to the same crystal system (monoclinic) with octahedral geometry, where the ruthenium atom is surrounded by hydrazone ligand coordinated through ON atoms, one chloride labile co‐ligand and the remaining three coordination sites covered by an electron cloud of p‐cymene moiety. The interaction between the complexes and DNA/bovine serum albumin (BSA) was evaluated using absorption and emission titration methods showing intercalative modes of interaction. The DNA cleavage ability of the complexes was checked by agarose gel electrophoresis method exhibiting the destruction of DNA duplex arrangement. To understand the interaction between ruthenium complex and DNA/BSA molecule, molecular docking studies were performed. In vitro cytotoxicity of the complexes was examined by the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay on human lung cancer cell line, A549, and found that at lower IC₅₀, cell growth inhibition has occurred. Similarly, the IC₅₀ values of the complexes treated with cancerous cell lines have produced a significant amount of lactase dehydrogenase and nitrite content in the culture medium, which were evaluated as apoptosis‐inducing factors, suggesting that the ruthenium (II) arene hydrazone complexes with pyrazole ligands have promising anticancer activities.     

Transfer hydrogenation of ketones catalysed by half‐sandwich (η6‐p‐cymene) ruthenium(II) complexes incorporating benzoylhydrazone ligands

Neutral half‐sandwich η⁶‐p ‐cymene ruthenium(II) complexes of general formula [Ru(η⁶‐p ‐cymene)Cl(L)] (HL = monobasic O, N bidendate benzoylhydrazone ligand) have been synthesized from the reaction of [Ru(η⁶‐p ‐cymene)(μ‐Cl)Cl]₂ with acetophenone benzoylhydrazone ligands. All the complexes have been characterized using analytical and spectroscopic (Fourier transform infrared, UV–visible, ¹H NMR, ¹³C NMR) techniques. The molecular structures of three of the complexes have been determined using single‐crystal X‐ray diffraction, indicating a pseudo‐octahedral geometry around the ruthenium(II) ion. All the ruthenium(II) arene complexes were explored as catalysts for transfer hydrogenation of a wide range of aromatic, cyclic and aliphatic ketones with 2‐propanol using 0.1 mol% catalyst loading, and conversions of up to 100% were obtained. Further, the influence of other variables on the transfer hydrogenation reaction, such as base, temperature, catalyst loading and substrate scope, was also investigated.     

Five‐coordinate dinuclar cobalt (II), copper (II), zinc (II) and cadmium (II) complexes with 4‐bromo‐N‐(2‐pyridinylmethylene)benzenamine: Synthesis,characterisation and methyl methacrylate polymerization

A series of late transition metal complexes, [(bpma)Co(μ – Cl)Cl] ₂ , [(bpma)Cu(μ – Cl)Cl] ₂ , [(bpma)Zn(μ – Cl)Cl] ₂ and [(bpma)Cd(μ – Br)Br] ₂ (where bpma is 4‐bromo‐N‐((pyridin‐2‐yl)methylene)benzenamine) have been synthesized and structurally characterized. The X‐ray structures of dimeric complexes [(bpma)M(μ – X)X] ₂ (M = Co, Cu and Zn, X = Cl; M = Cd, X = Br) showed a distorted 5‐coordinate trigonal bipyramidal geometry involving two nitrogen atoms of N,N‐bidentate ligand, two bridged and one terminal halogen atoms. The complex [(bpma)Cu(μ – Cl)Cl] ₂ revealed the highest catalytic activity for the polymerisation of methyl methacrylate in the presence of modified methylaluminoxane with an activity of 9.14 × 10⁴ g PMMA/mol·Cu·h at 60 °C and afforded syndiotactic poly (methylmethacrylate) (rr = 0.69).     

In‐ and Out‐of‐Cavity Interactions by Modulating the Size of Ruthenium Metallarectangles

Cationic (arene)ruthenium‐based tetranuclear complexes of the general formula [Ru₄(η⁶‐p‐cymene)₄(μ‐N∩N)₂(μ‐OO∩OO)₂]⁴⁺ were obtained from the dinuclear (arene)ruthenium complexes [Ru₂(η⁶‐p‐cymene)₂(μ‐OO∩OO)₂Cl₂] (p‐cymene=1‐methyl‐4‐(1‐methylethyl)benzene, OO∩OO=5,8‐dihydroxy‐1,4‐naphthoquinonato(2?), 9,10‐dihydroxy‐1,4‐anthraquinonato(2?), or 6,11‐dihydroxynaphthacene‐5,12‐dionato(2?)) by reaction with pyrazine or bipyridine linkers (N∩N=pyrazine, 4,4′‐bipyridine, 4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine]) in the presence of silver trifluoromethanesulfonate (CF₃SO₃Ag) (Scheme). All complexes 4 – 12 were isolated in good yield as CF₃SO salts, and characterized by NMR and IR spectroscopy. The host–guest properties of the metallarectangles incorporating 4,4′‐bipyridine and (4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine] linkers were studied in solution by means of multiple NMR experiments (1D, ROESY, and DOSY). The largest metallarectangles 10 – 12 incorporating (4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine] linkers are able to host an anthracene, pyrene, perylene, or coronene molecule in their cavity, while the medium‐size metallarectangles 7 – 9 incorporating 4,4′‐bipyridine linkers are only able to encapsulate anthracene. However, out‐of‐cavity interactions are observed between these 4,4′‐bipyridine‐containing rectangles and pyrene, perylene, or coronene. In contrast, the small pyrazine‐containing metallarectangles 4 – 6 show no interaction in solution with this series of planar aromatic molecules.     

Lysosome‐targeted potent half‐sandwich iridium(III) α‐diimine antitumor complexes

Fifteen organometallic Ir(III) half‐sandwich complexes ( 1A – 5C ) having the general formula [(η⁵‐Cp^x)Ir(N^N)Cl]PF₆ (Cp^x = Cp*, tetramethyl(phenyl)cyclopentadienyl (Cp^xph) or tetramethyl(biphenyl)cyclopentadienyl (Cp^xbiph); N^N = diamine) have been synthesized and characterized. The molecular structure of 1A was determined using single‐crystal X‐ray diffraction analysis. The hydrolysis of 1A – 5C was monitored using UV–visible spectra. Complexes 3A – 3C showed catalytic activity for the oxidation of NADH to NAD⁺, where 3C showed the highest turnover number of 29.9 within 450 min. Cytotoxicity examination by MTT assay was carried out against two human cancer cell lines (HeLa and A549) after 24 or 48 h drug treatment. The complexes showed high potency, where the most potent complex ( 3C ; IC₅₀ = 3.4 μM) was six times more active than cisplatin against A549 cells after 24 h drug exposure. Cytotoxic potency towards A549 cells increased with phenyl substitution on Cp ring: Cp^xbiph > Cp^xph > Cp*. In addition, the biological studies showed that 3C caused cell apoptosis and cell cycle arrest at G₁ phase in A549 cancer cells. Moreover, 3C increased the level of reactive oxygen species markedly after 24 h, which may provide an important basis for killing cancer cells. Confocal laser scanning microscopy was used to track 3C in A549 cells. The cellular localization experiment showed that 3C targeted lysosomes and caused lysosomal damage.     

Mononuclear Complexes of Platinum Group Metals Containing η6‐ and η5‐Cyclic Π‐Perimeter Hydrocarbon and Pyridylpyrazolyl Derivatives: Syntheses and Structural Studies

Piano‐stool‐shaped platinum group metal compounds, stable in the solid state and in solution, which are based on 2‐(5‐phenyl‐1H‐pyrazol‐3‐yl)pyridine ( L ) with the formulas [(η⁶‐arene)Ru( L )Cl]PF₆ {arene = C₆H₆ ( 1 ), p‐cymene ( 2 ), and C₆Me₆, ( 3 )}, [(η⁶‐C₅Me₅)M( L )Cl]PF₆ {M = Rh ( 4 ), Ir ( 5 )}, and [(η⁵‐C₅H₅)Ru(PPh₃)( L )]PF₆ ( 6 ), [(η⁵‐C₅H₅)Os(PPh₃)( L )]PF₆ ( 7 ), [(η⁵‐C₅Me₅)Ru(PPh₃)( L )]PF₆ ( 8 ), and [(η⁵‐C₉H₇)Ru(PPh₃)( L )]PF₆ ( 9 ) were prepared by a general method and characterized by NMR and IR spectroscopy and mass spectrometry. The molecular structures of compounds 4 and 5 were established by single‐crystal X‐ray diffraction. In each compound the metal is connected to N1 and N11 in a k² manner.     

Spectroscopic and electrochemical study for evaluating DNA interaction activity of 4‐(3‐halophenyl)‐6‐(pyridin‐2‐yl)pyrimidin‐2‐amine based piano stool Cp* Rh (III) and Ir (III) complexes

Six novel organometallic half sandwich complexes [(η5‐C₅Me₅)M(L^1–3)Cl]Cl.2H₂O were synthesized using [{(η⁵‐C₅Me₅)M(μ‐Cl)Cl₂], where M = Ir (III)/Rh (III) and L^1–3 = three pyridyl pyrimidine based ligands; and characterized by NMR, Infra‐red spectroscopy, conductance, elemental and thermal analysis. The complex‐DNA binding mode and/or strength evaluated using absorption titration, electrochemical studies and hydrodynamic measurement proposed intercalative binding mode, which was also confirmed by molecular docking study. Differential pulse voltammetry and cyclic voltammetry studies indicated an alteration in oxidation and reduction potentials of complexes (M⁺⁴/M⁺³) in presence of CT‐DNA. The metal complexes can cleave plasmid DNA as proposed in gel electrophoretic analysis. The LC₅₀ values of complexes evaluated on brine shrimp suggested their potent cytotoxic nature.     

Unusual coordination mode of aroyl/acyl thiourea ligands and their π‐arene ruthenium (II) piano‐stool complexes: Synthesis,molecular geometry,theoretical studies and biological applications

Two mononuclear ruthenium complexes ( 1 and 2 ) with aroyl/acylthiourea as an ancillary ligand of type, [(η⁶‐p‐cymene)RuCl(L‐N,S)], where [ L1  = 2,4‐dichloro‐N‐(o‐tolylcarbamothioyl)benzamide] and L2  = N‐(phenylcarbamothioyl)cyclohexanecarboxamide] were synthesized and well characterized. The single crystal X‐ray diffraction studies revealed the coordination mode and the geometry of the complexes. The two complexes adopted general piano‐stool (three‐legged) geometry with a novel coordination mode of aroyl/acylthiourea through amide N (anionic) and thiocarbonyl S (neutral). This type of monobasic bidentate coordination of the aroyl/acylthiourea ligand was witnessed the first time around the metal ion. The coordination of the complexes was well explained through geometric parameters and frontier molecular orbital parameter values computed at the B3LYP/SDD level. The synthesized complexes were also screened for their antibacterial, antifungal, antioxidant and in vitro antiproliferative activities. Complexes exhibited good antimicrobial agents against various pathogens. The antioxidant activity of the complex 2 has shown most potent activity with IC₅₀ value of 48.55 ± 1.7 μM compared to the reference drug. In addition, the in vitro antiproliferative activity of the complex 2 showed excellent activity against HepG‐2 cell line with the IC₅₀ value of 24.30 ± 1.20 μM which is close to Doxorubicin standard drug.     

Synthesis of Imines via Reactions of Benzyl Alcohol with Amines Using Half‐Sandwich (η6‐p‐cymene) Ruthenium(II) Complexes Stabilised by 2‐aminofluorene Derivatives

A new class of half‐sandwich (η⁶‐p‐cymene) ruthenium(II) complexes supported by 2‐aminofluorene derivatives [Ru(η⁶‐p‐cymene)(Cl)(L)] ( L  = 2‐(((9H‐fluoren‐2‐yl)imino)methyl)phenol ( L ¹ ), 2‐(((9H‐fluoren‐2‐yl)imino)methyl)‐3‐methoxyphenol ( L ² ), 1‐(((9H‐fluoren‐2‐yl)imino)methyl)naphthalene‐2‐ol ( L ³ ) and N‐((1H‐pyrrol‐2‐yl)methylene)‐9H‐fluorene‐2‐amine ( L ⁴ )) were synthesized. All compounds were fully characterized by analytical and spectroscopic techniques (IR, UV–Vis, NMR) and also by mass spectrometry. The solid state molecular structures of the complexes [Ru(η⁶‐p‐cymene)(Cl)(L²)], [Ru(η⁶‐p‐cymene)(Cl)(L³)] and [Ru(η⁶‐p‐cymene)(Cl)(L⁴)] revealed that the 2‐aminofluorene and p‐cymene moieties coordinate to ruthenium(II) in a three‐legged piano‐stool geometry. The synthesized complexes were used as catalysts for the dehydrogenative coupling of benzyl alcohol with a range of amines (aliphatic, aromatic and heterocyclic). The reactions were carried out under thermal heating, ultrasound and microwave assistance, using solvent or solvent free conditions, and the catalytic performance was optimized regarding the solvent, the type of base, the catalyst loading and the temperature. Moderately high to very high isolated yields were obtained using [Ru(η⁶‐p‐cymene)(Cl)(L⁴)] at 1 mol%. In general, microwave irradiation produced better yields than the other two techniques irrespective of the nature of the substituents.     

Syntheses and Structures of Homo‐ and Heterobimetallic Complexes Containing a (Cyclopentadienone)rhodium(I) Fragment

The reaction of [RhCl(η⁴‐Ph₂R₂C₄CO)]₂ (R=Ph, 2‐naphthyl) with the dimeric complexes [RuCl₂(p‐cymene)]₂ p‐cymene=1‐methyl‐4‐(1‐methylethyl)benzene, [RuCl₂(1,3,5‐Et₃C₆H₃)]₂, [MCl₂(Cp*)]₂ (M=Rh, Ir; Cp*=1,2,3,4,5‐pentamethylcyclopenta‐2,4‐dien‐1‐yl), [RuCl₂(CO)₃]₂, [RuCl₂(dcypb)(CO)]₂ (dcypb=butane‐1,4‐diylbis[dicyclohexylphosphine]), [(dppb)ClRu(μ‐Cl)₂(μ‐OH₂)RuCl(dppb)] (dppb=butane‐1,4‐diylbis[diphenylphosphine]), and [(dcypb)(N₂)Ru(μ‐Cl)₃RuCl(dcypb)] was investigated. In all cases, mixed, chloro‐bridged complexes were formed in quantitative yield (see 5 – 8, 9 – 16, 18, 19, 21 , and 22 ). The six new complexes 5, 8, 9, 13, 15 , and 22 were characterized by single‐crystal X‐ray analysis (Figs. 1–3).     

Ruthenium–Arene–β‐Carboline Complexes as Potent Inhibitors of Cyclin‐Dependent Kinase 1: Synthesis,Characterization and Anticancer Mechanism Studies

A series of Ru^II–arene complexes ( 1 – 6 ) of the general formula [(η⁶‐arene)Ru(L)Cl]PF₆ (arene=benzene or p‐cymene; L=bidentate β‐carboline derivative, an indole alkaloid with potential cyclin‐dependent kinases (CDKs) inhibitory activities) is reported. All the complexes were fully characterized by classical analytical methods, and three were characterized by X‐ray crystallography. Hydrolytic studies show that β‐carboline ligands play a vital role in their aqueous behaviour. These complexes are highly active in vitro, with the most active complex 6 displaying a 3‐ to 12‐fold higher anticancer activity than cisplatin against several cancer cell lines. Interestingly, the complexes are able to overcome cross‐resistance to cisplatin, and show much lower cytotoxicity against normal cells. Complexes 1 – 6 may directly target CDK1, because they can block cells in the G2M phase, down‐regulate the expression of CDK1 and cyclin B1, and inhibit CDK1/cyclin B in vitro. Further mechanism studies show that the complexes can effectively induce apoptosis through mitochondrial‐related pathways and intracellular reactive oxygen species (ROS) elevation.     

SBA‐15‐supported N‐coordinate ruthenium(II) materials bearing sulfonamide‐type ligands: Effect of ligand backbones on catalytic transfer hydrogenation of ketones and aldehydes

[RuLCl(p ‐cymene)] (L = N ‐arylsulfonylphenylenediamine) complexes ( 2 _{a – d} ) were synthesized from the reaction between [Ru(p ‐cymene)Cl₂]₂ and ligand. Additionally, SBA‐15–[RuLCl(p ‐cymene)] derived catalysts ( 3 _{a – d} ) were successfully immobilized onto mesoporous silica (SBA‐15) by an easily accessible approach. The structural elucidations of 2 _{a – d} and 3 _{a – d} were carried out with various methods such as ¹H NMR, ¹³C NMR and infrared spectroscopies, elemental analysis, thermogravimetric/differential thermal analysis, nitrogen adsorption–desorption and scanning electron microscopy/energy‐dispersive X‐ray analysis. The Ru(II) complexes and materials were found to be highly active and selective catalysts for the transfer hydrogenation (TH) reaction of aldehydes and ketones. The influence of various 1,2‐phenylenediamines on the reactivity of the catalysts (complexes or materials) was studied and the catalysts ( 2 _d and 3 _d ) with a 4,5‐dichlorophenylenediamine substituent showed the best activity (the maximum turnover frequencies are 2916 and 2154 h⁻¹ for TH of 4‐fluoroacetophenone, and 6000 and 4956 h⁻¹ for TH of 4‐chlorobenzaldehyde).     

Synthesis and Structures of Arene Ruthenium (II)–NHC Complexes: Efficient Catalytic α‐alkylation of ketones via Hydrogen Auto Transfer Reaction

A panel of six new arene Ru (II)‐NHC complexes 2a‐f , (NHC = 1,3‐diethyl‐(5,6‐dimethyl)benzimidazolin‐2‐ylidene 1a , 1,3‐dicyclohexylmethyl‐(5,6‐dimethyl)benzimidazolin‐2‐ylidene 1b and 1,3‐dibenzyl‐(5,6‐dimethyl)benzimidazolin‐2‐ylidene 1c ) were synthesized from the transmetallation reaction of Ag‐NHC with [(η⁶‐arene)RuCl₂]₂ and characterized. The ruthenium (II)‐NHC complexes 2a‐f were developed as effective catalysts for α‐alkylation of ketones and synthesis of bioactive quinoline using primary/amino alcohols as coupling partners respectively. The reactions were performed with 0.5 mol% catalyst load in 8 h under aerobic condition and the maximum yield was up to 96%. Besides, the different alkyl wingtips on NHC and arene moieties were studied to differentiate the catalytic robustness of the complexes in the transformations.     

Synthesis, characterization of novel half-sandwich iridium and rhodium complexes containing pyridine-based organochalcogen ligands

A series of neutral pyridine-based organochalcogen ligands, 2,6-bis(1-methylimidazole-2-thione)pyridine (Bmtp), 2,6-bis(1-isopropylimidazole-2-thione)pyridine (Bptp), and 2,6-bis(1-tert-butylimidazole-2-thione)pyridine (Bbtp) have been synthesized and characterized. Reactions of [Cp*M(μ-Cl)Cl]₂ (Cp* = η⁵-pentamethylcyclopentadienyl, M = Ir, Rh) with three pyridine-based organochalcogen ligands result in the formation of the complexes Cp*M(L)Cl₂ (M = Ir, L = Bmtp, 1a·Cl₂; M = Rh, L = Bmtp, 1b·Cl₂; M = Ir, L = Bptp, 2a·Cl₂; M = Rh, L = Bptp, 2b·Cl₂; M = Ir, L = Bbtp, 3a·Cl₂; M = Rh, L = Bbtp, 3b·Cl₂), respectively. All compounds have been characterized by elemental analysis, NMR and IR spectra. The molecular structures of Bbtp, 1a·Cl₂, 1b·Cl₂, 2b·Cl₂ and 3b·Cl₂ have been determined by X-ray crystallography.     

Selenoquinones Stabilized by Ruthenium(II) Arene Complexes: Synthesis,Structure, and Cytotoxicity

A new series of monoselenoquinone and diselenoquinone π complexes, [(η⁶‐p‐cymene)Ru(η⁴‐C₆R₄SeE)] (R=H, E=Se ( 6 ); R=CH₃, E=Se ( 7 ); R=H, E=O ( 8 )), as well as selenolate π complexes [(η⁶‐p‐cymene)Ru(η⁵‐C₆H₃R₂Se)][SbF₆] (R=H ( 9 ); R=CH₃ ( 10 )), stabilized by arene ruthenium moieties were prepared in good yields through nucleophilic substitution reactions from dichlorinated‐arene and hydroxymonochlorinated‐arene ruthenium complexes [(η⁶‐p‐cymene)Ru(C₆R₄XCl)][SbF₆]₂ (R=H, X=Cl ( 1 ); R=CH₃, X=Cl ( 2 ); R=H, X=OH ( 3 )) as well as the monochlorinated π complexes [(η⁶‐p‐cymene)Ru(η⁵‐C₆H₃R₂Cl)][SbF₆]₂ (R=H ( 4 ); R=CH₃ ( 5 )). The X‐ray crystallographic structures of two of the compounds, [(η⁶‐p‐cymene)Ru(η⁴‐C₆Me₄Se₂)] ( 7 ) and [(η⁶‐p‐cymene)Ru(η⁴‐C₆H₄SeO)] ( 8 ), were determined. The structures confirm the identity of the target compounds and ascertain the coordination mode of these unprecedented ruthenium π complexes of selenoquinones. Furthermore, these new compounds display relevant cytotoxic properties towards human ovarian cancer cells.